関連する実験動画
Updated: Jul 23, 2026

23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
スケールアップ:世界的な結核対策の目標達成
Gijs Elzinga1, Mario C Raviglione, Dermot Maher
1RIVM (National Institute for Public Health and the Environment), Bilthoven, Netherlands.
Lancet (London, England)
|March 16, 2004
まとめ
世界的な結核対策目標は,症例検出の大きなギャップのために見逃されることがあります. 重要な行動には,国家プログラムの強化,地域社会の関与,そして,結核と闘うためにサハラ以南のアフリカへの支援の拡大が含まれます.
科学分野:
- 公衆衛生は公衆衛生である.
- 感染症疫学 感染症疫学
背景:
- 世界的な結核 (TB) 制御目標の達成は,特に症例検出と治癒率に関する課題に直面しています.
- 推定されたインシデントTB症例と,直接観察された短期治療 (DOTS) 戦略の下で報告された症例の間に顕著なギャップが存在します.
- 遅れた進歩は,特にサハラ以南のアフリカや旧ソビエト連邦のような高発生率の地域で,結核の発生率に影響を与えます.
研究 の 目的:
- グローバルな結核管理目標に向けた進展を加速するために必要な重要な行動を特定する.
- 症例検出のギャップを埋め,TB対策戦略の有効性を向上させる.
主な方法:
- 世界の結核対策の現状を分析する.
- プログラムの強化と拡張に必要な重要な戦略的行動を特定する.
主要な成果:
- 2005年の世界結核目標を達成するための進展は,症例検出の不足のために危険にさらされています.
- 結核対策を早めるために4つの主要な行動が提案されています:国家結核プログラムの管理を強化し,DOTSのカバー認証を評価し,コミュニティの関与を促進し,サハラ以南のアフリカで結核/HIVの共感染に対する支援を増やすことです.
結論:
- 結核症例検出のギャップを埋めるために,緊急かつ戦略的な介入が必要であり,世界的な制御目標を達成する必要があります.
- 強化された国家プログラムの能力,地域社会の参加,および標的型支援は,効果的な結核管理に不可欠であり,特に共感染に直面する高負荷地域において重要である.
関連する概念動画
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

